TITLE:
4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?

CONDITION:
Alpha 1-Antitrypsin Deficiency

INTERVENTION:
4-PBA

SUMMARY:

      The purpose of this study is to find out whether 4-PBA will increase the level of AAT in
      persons with AAT deficiency whether or not they have liver disease.
    

DETAILED DESCRIPTION:

      The purpose of this study is to determine whether 4-PBA will significantly increase serum Z
      AAT levels in AAT-deficient individuals with and without evidence of hepatocellular injury
      and to assess its effects on liver injury.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Age 18-65

          -  Serum A1-PI levels <11uM an appropriate genetic phenotype/genotype

          -  5 of 10 subjects must have documented laboratory evidence of liver disease

          -  Willingness to withhold Prolastin therapy for 6 weeks prior to screening and
             throughout the 4-PBA dosing period (up to 3 months)

        Exclusion Criteria:

          -  Any cause of liver disease other than Alpha-1 Antitrypsin deficiency

          -  Evidence of advanced liver disease

          -  HIV positive

          -  Use of systemic steroids, ursodeoxycholic acid (Actigall, Urso), or herbs in the
             prior 6 months
      
